Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Athens Euroclinic
Study identified no predictors of sustained ventricular tachycardia
November 4th, 2005
Researchers have investigated sustained ventricular tachycardia induced by dobutamine stress echocardiography. Investigators in Greece conducted a study "to investigate the prognostic significance and electrophysiological characteristics of dobutamine stress echo (DSE)-induced sustained monomorphic ventricular tachycardia (VT)." D.G. Katritsis and colleagues of the Athens Euroclinic explained, "In our department, 3,022 DSE studies were carried out on 2,688 patients, aged 54.7±11.8 years, over a 3.5 year period. Patients with DSE-induced VT were studied by means of coronary angiography and electrophysiological testing, and were followed-up for...
Source: Biotech Law Weekly (2005-11-04)
|